New Frontier Data presents the 2023 archetypes of cannabis consumers in America. The report highlights nine consumer archetypes based on the latest consumer survey data.

The first archetype is Savvy Connoisseurs, comprising 13% of consumers. They are heavy cannabis users who consume it multiple times a day for various medical and recreational purposes. They obtain cannabis from both legal sources like dispensaries and informal channels such as friends or illicit dealers. Savvy Connoisseurs are the highest spenders and often purchase cannabis weekly.

The second archetype is Contemporary Lifestylers, representing 16% of consumers. They primarily use cannabis recreationally to relax. They prefer smokable cannabis but also try non-smokable products occasionally. All Contemporary Lifestylers live in states where cannabis use is legal and rely on regulated sources like dispensaries. They are moderate-to-high spenders and frequently acquire cannabis.

The third archetype, Medical Lifestylers, makes up 12% of consumers. They are frequent cannabis users who primarily use smokable products but occasionally explore edibles or other non-smokable forms. Medical Lifestylers consume cannabis for medical reasons, such as pain management or treating medical conditions. They mainly obtain cannabis from legal dispensaries and delivery services. Medical Lifestylers are the second-highest spenders after Savvy Connoisseurs.

The fourth archetype, Legacy Lifestylers, represents 13% of consumers. Like other Lifestyler archetypes, Legacy Lifestylers are frequent cannabis consumers who predominantly smoke cannabis for recreational purposes. However, they live in states where cannabis is illegal or are unregistered patients in medical-only states, limiting their access to legal dispensaries. Therefore, they primarily rely on friends and illicit dealers for their cannabis supply. Legacy Lifestylers acquire cannabis with similar frequency as their legal counterparts and spend only slightly less per purchase.

The data highlights changes in consumer distribution among the archetypes compared to the previous year. The Legacy Lifestyler archetype has decreased from 16% to 13% due to the expansion of legal access to cannabis in several states. As more states legalize cannabis, Legacy Lifestylers are expected to transition into the Contemporary and Medical Lifestyler archetypes based on their medical or recreational goals. Over time, exposure to a wider range of legal cannabis products may lead them to prefer non-smokable options and potentially shift to other archetypes.

The Savvy Connoisseur archetype has also reduced in size from 18% to 13%, potentially influenced by new consumers entering the market and pandemic-related changes in consumption habits. Consumers in newly legal markets may have established their preferred products and routines, requiring less experimentation. As cannabis becomes more mainstream, the need to educate friends about new products or procure products for social circles may also decrease.

For effective communication with these consumer segments, the article suggests reaching out to NXTeck’s B2C division, which specializes in delivering targeted digital campaigns in the cannabis industry. NXTeck offers audience targeting, analytics, and attribution reporting based on location, point-of-sale, and social science data, utilizing the industry’s largest cannabis and CBD consumer audience dataset.

For further information on the consumer archetypes, the complete report will be released next month. For inquiries, contact NXTeck via email at sales@nxteck.com.

 

Source: NewFrontierData

EXPLORE MORE NEWS

Major Corporations Investing in Cannabis

As cannabis legalization continues to spread across the country, major corporations are increasingly taking notice and investing in the industry. In April of 2023, a major beverage company announced a $100 million investment in a cannabis-infused drink startup, signaling the growing trend of large corporations entering the cannabis space.

Alabama Medical Cannabis Commission Grants Licenses to 21 Companies

In a significant step toward the implementation of Alabama’s medical cannabis program, the Alabama Medical Cannabis Commission has awarded licenses to 21 companies. This groundbreaking development marks a significant milestone in the state’s efforts to provide access to medical cannabis for eligible patients. The diverse array of licensed companies is expected to contribute to the availability and variety of medical cannabis products throughout Alabama.

The Art and Science of Cannabis Cultivation: Unveiling the Secrets Behind Strains

Cannabis cultivation is a captivating journey that blends artistry and scientific expertise. It is a process where cultivators meticulously select and nurture cannabis strains to produce the desired qualities, such as potency, flavor, and aroma. This article explores the intricacies of cannabis cultivation, unveiling the vast array of strains available in the market and shedding light on the craft behind their creation. It delves into both the art and science behind cannabis cultivation, highlighting the cultivation techniques used within the industry to achieve the desired outcomes.

Proximity Matters: How Closeness to Cannabis Stores Drives Legal Market Sales in Canada

New research on Canada’s regulated cannabis market has shed light on consumer preferences and their impact on marijuana sales. The study, set to be published in the Journal of Studies on Alcohol and Drugs, explores the relationship between consumers’ proximity to government-regulated cannabis stores and their purchasing decisions.

Newsletter